Screener
Nuvation Bio NUVB EBITDA
Discontinued — last reported Q2 '26
EBITDA at other companies
Other financials
Where this comes from
Calculated from Nuvation Bio’s reported figures.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
FAQ
- What is Nuvation Bio's EBITDA?
- Nuvation Bio (NUVB) reported EBITDA of -$50.5M in Q2 2026.
- How has Nuvation Bio's EBITDA changed year-over-year?
- Nuvation Bio's EBITDA increased by 20.1% year-over-year, from -$63.23M to -$50.5M.
- What is the long-term trend for Nuvation Bio's EBITDA?
- Over 4 years (2021 to 2025), Nuvation Bio's EBITDA has grown at a 22.7% compound annual growth rate (CAGR), from -$93.13M to -$211.33M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Nuvation Bio's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude